Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Manuel Soto-Catalan"'
Autor:
Lucas Opazo-Rios, Manuel Soto-Catalan, Iolanda Lázaro, Aleix Sala-Vila, Cristian Pérez-Gallardo, Fabian Segovia-Miranda, Juan Antonio Moreno, Jesús Egido, Sebastián Mas-Fontao
Publikováno v:
Annals of Hepatology, Vol 28, Iss , Pp 100906- (2023)
Introduction and Objectives: The new recommendations suggesting changing the current nomenclature from Non-Alcoholic Fatty Liver Disease (NAFLD) to Metabolic associated fatty liver disease (MAFLD) are primarily aimed at improving the understanding of
Externí odkaz:
https://doaj.org/article/c872cd79e05b4246a16d87507c1b5579
Autor:
Lucas Opazo-Ríos, Antonio Tejera-Muñoz, Manuel Soto Catalan, Vanessa Marchant, Carolina Lavoz, Sebastián Mas Fontao, Juan Antonio Moreno, Marta Fierro Fernandez, Ricardo Ramos, Beatriz Suarez-Alvarez, Carlos López-Larrea, Marta Ruiz-Ortega, Jesús Egido, Raúl R. Rodrigues-Díez
Publikováno v:
Frontiers in Pharmacology, Vol 13 (2022)
Diabetic nephropathy (DN) is the main leading cause of chronic kidney disease worldwide. Although remarkable therapeutic advances have been made during the last few years, there still exists a high residual risk of disease progression to end-stage re
Externí odkaz:
https://doaj.org/article/1da83a47d26d4589802051a891591700
Autor:
Luna Jiménez-Castilla, Lucas Opazo-Ríos, Gema Marin-Royo, Macarena Orejudo, Raquel Rodrigues-Diez, Constanza Ballesteros-Martínez, Manuel Soto-Catalán, Teresa Caro-Ordieres, Inés Artaiz, Tatiana Suarez-Cortés, Arturo Zazpe, Gonzalo Hernández, Marcelino Cortés, José Tuñón, Ana M. Briones, Jesús Egido, Carmen Gómez-Guerrero
Publikováno v:
Antioxidants, Vol 11, Iss 12, p 2499 (2022)
In diabetes, chronic hyperglycemia, dyslipidemia, inflammation and oxidative stress contribute to the progression of macro/microvascular complications. Recently, benefits of the use of flavonoids in these conditions have been established. This study
Externí odkaz:
https://doaj.org/article/f21f58fee26c4c3f8fd39993ac6c03df